TTM
$9.09B
YoY change
-25.7%
5Y CAGR
-1.9%
Peak year (2018)
$9.46B
Cumulative EBITDA
$164.52B
EBITDA history chart for Medtronic (MDT) from 1986 to 2026
Latest: $6.85B
EBITDA growth chart for Medtronic (MDT) from 1986 to 2026
Latest: -25.7%
EBITDA history table for Medtronic (MDT) from 1986 to 2026
| 2026 | $6.85B | -25.7% | −$2.37B | ||
| 2025 | $9.22B | +12.4% | +$1.01B | ||
| 2024 | $8.20B | -5.7% | −$494.00M | ||
| 2023 | $8.70B | -0.9% | −$80.00M | ||
| 2022 | $8.78B | +16.7% | +$1.25B | ||
| 2021 | $7.52B | -3.7% | −$288.00M | ||
| 2020 | $7.81B | -16.0% | −$1.49B | ||
| 2019 | $9.30B | -1.7% | −$165.00M | ||
| 2018 | $9.46B | +9.9% | +$852.00M | ||
| 2017 | $8.61B | +0.8% | +$71.00M | ||
| 2016 | $8.54B | +56.5% | +$3.08B | ||
| 2015 | $5.46B | +10.6% | +$524.00M | ||
| 2014 | $4.93B | -9.6% | −$524.00M | ||
| 2013 | $5.46B | +2.5% | +$131.00M | ||
| 2012 | $5.33B | +8.3% | +$409.00M | ||
| 2011 | $4.92B | -3.9% | −$200.00M | ||
| 2010 | $5.12B | +45.8% | +$1.61B | ||
| 2009 | $3.51B | -7.1% | −$267.00M | ||
| 2008 | $3.78B | -12.6% | −$545.00M | ||
| 2007 | $4.32B | +1.7% | +$73.00M | ||
| 2006 | $4.25B | +8.8% | +$342.00M | ||
| 2005 | $3.91B | +7.8% | +$283.00M | ||
| 2004 | $3.62B | +18.4% | +$562.30M | ||
| 2003 | $3.06B | +23.5% | +$582.90M | ||
| 2002 | $2.48B | +13.9% | +$303.10M | ||
| 2001 | $2.18B | +12.9% | +$248.30M | ||
| 2000 | $1.93B | +22.0% | +$347.90M | ||
| 1999 | $1.58B | +25.5% | +$321.30M | ||
| 1998 | $1.26B | +20.4% | +$212.90M | ||
| 1997 | $1.05B | +39.7% | +$297.30M | ||
| 1996 | $748.00M | +37.8% | +$205.20M | ||
| 1995 | $542.80M | +32.0% | +$131.60M | ||
| 1994 | $411.20M | +12.8% | +$46.50M | ||
| 1993 | $364.70M | +19.4% | +$59.30M | ||
| 1992 | $305.40M | +20.8% | +$52.50M | ||
| 1991 | $252.90M | +23.7% | +$48.50M | ||
| 1990 | $204.40M | +17.3% | +$30.10M | ||
| 1989 | $174.30M | +9.6% | +$15.20M | ||
| 1988 | $159.10M | +20.4% | +$27.00M | ||
| 1987 | $132.10M | +32.6% | +$32.50M | ||
| 1986 | $99.60M | — | — |
- 2026$6.85B-25.7%
- 2025$9.22B+12.4%
- 2024$8.20B-5.7%
- 2023$8.70B-0.9%
- 2022$8.78B+16.7%
- 2021$7.52B-3.7%
- 2020$7.81B-16.0%
- 2019$9.30B-1.7%
- 2018$9.46B+9.9%
- 2017$8.61B+0.8%
- 2016$8.54B+56.5%
- 2015$5.46B+10.6%
- 2014$4.93B-9.6%
- 2013$5.46B+2.5%
- 2012$5.33B+8.3%
- 2011$4.92B-3.9%
- 2010$5.12B+45.8%
- 2009$3.51B-7.1%
- 2008$3.78B-12.6%
- 2007$4.32B+1.7%
- 2006$4.25B+8.8%
- 2005$3.91B+7.8%
- 2004$3.62B+18.4%
- 2003$3.06B+23.5%
- 2002$2.48B+13.9%
- 2001$2.18B+12.9%
- 2000$1.93B+22.0%
- 1999$1.58B+25.5%
- 1998$1.26B+20.4%
- 1997$1.05B+39.7%
- 1996$748.00M+37.8%
- 1995$542.80M+32.0%
- 1994$411.20M+12.8%
- 1993$364.70M+19.4%
- 1992$305.40M+20.8%
- 1991$252.90M+23.7%
- 1990$204.40M+17.3%
- 1989$174.30M+9.6%
- 1988$159.10M+20.4%
- 1987$132.10M+32.6%
- 1986$99.60M—
EBITDA values are taken from Medtronic's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Medtronic (MDT)
According to Medtronic's latest reported financial statements, the company's current EBITDA (TTM) is $9.09B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2026 fiscal year, Medtronic (MDT) reported EBITDA of $6.85B – declined 25.7% year-over-year.
Looking at the 2021–2026 (5 years) stretch, Medtronic EBITDA compounded at -1.9% per year, with a net decline across the window.
Medtronic EBITDA declined from $9.46B in 2018 to $6.85B in 2026, a 27.6% drawdown.
The highest annual EBITDA of $9.46B was reported in 2018. The lowest in the available history was $99.60M in 1986.
Medtronic EBITDA by Year
Medtronic EBITDA 2026: $6.85B
Medtronic posted EBITDA of $6.85B in 2026, declined 25.7% below 2025.
Medtronic EBITDA 2025: $9.22B
In 2025, Medtronic reported EBITDA of $9.22B, grew 12.4% from 2024.
Medtronic EBITDA 2024: $8.20B
Medtronic EBITDA in 2024 was $8.20B, declined 5.7% below 2023.
Medtronic EBITDA 2023: $8.70B
2023's EBITDA for Medtronic came in at $8.70B, edged down 0.9% below 2022.
Medtronic EBITDA 2022: $8.78B
Medtronic EBITDA in 2022 was $8.78B.
See more financial history for Medtronic (MDT).
Sector peers by EBITDA
Healthcare peers of Medtronic (MDT), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation